World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02048592
Date of registration: 16/12/2013
Prospective Registration: No
Primary sponsor: University Hospital, Motol
Public title: Impact of Immunonutrition on the Patients With Cystic Fibrosis
Scientific title: Impact of Immunonutrition on the Patients With Cystic Fibrosis
Date of first enrolment: September 2013
Target sample size: 30
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02048592
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care  
Phase:  Phase 4
Countries of recruitment
Czech Republic
Contacts
Name:     Jiri Charvat, MD
Address: 
Telephone:
Email:
Affiliation:  Faculty hospital Motol
Name:     Libor Fila, MD
Address: 
Telephone: +420224436630
Email: libor.fila@fnmotol.cz
Affiliation: 
Name:     Ondrej Hloch, MD
Address: 
Telephone: +420224434098
Email: o.hloch@gmail.com
Affiliation: 
Name:     Milan Kvapil, MD
Address: 
Telephone:
Email:
Affiliation:  Faculty hospital Motol
Name:     Ondrej Hloch, MD
Address: 
Telephone:
Email:
Affiliation:  Faculty hospital Motol
Key inclusion & exclusion criteria

Inclusion Criteria:

- Cystic fibrosis

- adult, elder 18 years

- enteral nutrition at least for the last 12 monthes

Exclusion Criteria:

- patient waiting for lung transplant

- patients with another life limiting disease-e.g. cancers



Age minimum: 18 Years
Age maximum: 40 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Oxidative Stress
Cystic Fibrosis
Malnutrition
Intervention(s)
Dietary Supplement: Impact-Nutridrink
Dietary Supplement: Nutridrink-Impact
Primary Outcome(s)
to evaluate the change of oxidative stress in patients with cystic fibrosis induced by immunonutrition [Time Frame: 16 weeks]
Secondary Outcome(s)
to evaluate the change of inflammatory parameters in patients with cystic fibrosis induced by the application of immunonutrition [Time Frame: 16 weeks]
Secondary ID(s)
FN Motol-project 6008
EK-942/13
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history